Verition Fund Management
MLAB icon

Verition Fund Management’s Mesa Laboratories MLAB Stock Holding History

Verition Fund Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,100
Closed -$249K – 3772
2025
Q1 		$249K Buy
+2,100
New +$286K ﹤0.01% 2946

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM

Verition Fund Management's MLAB Position: Q2 2025 in Review

Verition Fund Management sold out of Mesa Laboratories (MLAB) in Q2 2025, closing a stake of 2,100 shares — an estimated $249K sold.

Verition Fund Management first reported a position in MLAB in Q1 2025 and held it in 1 quarter. The position peaked at $249K in Q1 2025. 154 funds tracked by Wall St. Rank hold MLAB as of Q2 2025.

  • Verition Fund Management reported no remaining Mesa Laboratories position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 2,100 Mesa Laboratories shares in Q2 2025, an estimated $249K.
  • Verition Fund Management first reported a position in Mesa Laboratories in Q1 2025 and held it in 1 quarter.
  • Verition Fund Management's Mesa Laboratories position peaked at $249K in Q1 2025.
  • 154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.